📍We found that adherence to reporting standards improved w time
📍Reporting quality was better in journals w IF >45 (vs<45)
📍Implementation of #CONSORT checklists at grant/manuscript submission & peer review stage may improve reporting across journals
doi.org/10.1002/ejhf.3…

A bold new vision for JACC Journals under Harlan Krumholz 🔥

✅ One of the fastest “door-to-decision” times
✅ Author centric in design
✅ Personal & approachable editorial team
✅ Impact multiplier w next gen dissemination & amplification

Make JACC Journals 1st choice for CV science!

As Swapnil Hiremath @[email protected] points out, our task at implementation is going to become even more critical after FLOW

We need to reimagine, develop & refine a new framework that addresses urgency of optimising GDMT in ppl at high cardio-renal risk

Full text in Circulation ahajournals.org/doi/10.1161/CI…

At #ACC24 , I sat down with the meeting's Young Investigator Award winner @SafChat to discuss her analysis of PARADIGM-HF and 2024 KDIGO Risk Classifications.

Learn more:
hcplive.com/view/safia-cha…

Muthu Vaduganathan Brendon Neuen scottdavidsolomon #HeartFailure #HFrEF ACC Media Center

Dr. Ankeet S. Bhatt, MD, MBA elegantly explains our most recent findings from the NUDGE-FLU trail in citizens with a previous MI. Great job my friend!

academic.oup.com/eurheartj/adva…

CTCPR Trials & CIRL Herlev og Gentofte hosp afd for hjertesygdomme Niklas Dyrby Johansen Muthu Vaduganathan Department of Biomedical Sciences | UCPH University of Copenhagen Research HerlevGentofte Hosp. Brigham and Women’s Research

What a memorable #ACC24 sharing new science in the #YIA session and connecting with friends!

Beyond grateful to Muthu Vaduganathan for his truly exceptional mentorship!!!!

#simpub with insights on #ARNI in HF across kidney risk: jacc.org/doi/10.1016/j.… #simpub

Wonderful to present at #ACC24 and connect with great colleagues on practice-changing science 🧬🫀 #ACCinTouch

G B John Mancini Liam Brunham Eugenia Gianos MD Erin D. Michos, M.D. Carol Kirkpatrick, PhD, MPH, RDN, CLS, FNLA Karen Aspry Rob Ostfeld, MD, MSc Pam R. Taub, MD❤️💃🏻 Diana Vikulova Josh Liberman McGill_DOM UBC Department of Medicine

Outstanding #ACC24 American College of Cardiology all around with a wealth of practice-changing science. Congratulations to all the investigators. Great to see everyone in ATL.

Especially proud and grateful to be able to work with this crew!

So proud of Safia Chatur, MD on the stellar Young Investigator Award presentation with simultaneous publication in JACC Journals!

Effects of #ARNI in #HF across the Spectrum of Kidney Risk in #PARADIGMHF

jacc.org/doi/10.1016/j.…

Excellent presentation by Maria A. Pabón, MD on sex differences in HFimpEF in #DELIVER @ #ACC .24 w #simpub now in #JACCHF jacc.org/doi/10.1016/j.…

Congrats to Safia Chatur, MD on winning the young investigator award. Such an inspiration for all of us Muthu Vaduganathan scottdavidsolomon

#ACC24 #SimPub by Alberto Foà in JACC Journals

Fascinating observation from #PARAGONHF — pts w LVEF above 60% were at *higher* risk of hypotension & *lower* likelihood of benefit w #ARNI sacubitril/valsartan

Reinforces current guidance for pt selection

jacc.org/doi/10.1016/j.…

#ACC24 #SimPub in #EJHF by Ankeet S. Bhatt, MD, MBA

Highlighted Original Research in #HF / #Cardiomyopathy Year in Review

#ARNI associated with lower risk of all-cause and CV hospitalizations compared with #RASi in US real world cohort of pts with HF & LVEF>40%

onlinelibrary.wiley.com/doi/abs/10.100…

#ACC24 #JACC SimPub: New from #PARADIGMHF - #ARNI exhibits consistent safety and efficacy across the continuum of #KDIGO kidney risk. bit.ly/3J8z5hv

#HFrEF #CKD Safia Chatur, MD Iris Beldhuis scottdavidsolomon Muthu Vaduganathan University of Glasgow Heart Failure Research Group

. Brigham and Women’s Research Clinical Trials Outcomes Center & Friends

Simultaneous Publications with American College of Cardiology #ACC24 across JACC Journals Circulation European Society of Cardiology & JAMA Cardiology

Tor Biering-Sørensen, MD, MSc, MPH, PhD is a star in every way. What he and the team at CTCPR Trials & CIRL have done to date has set the standard for large, fast, pragmatic, simple trials. Proud to call him a friend and colleague.Muthu Vaduganathan.

Exciting to see our meta-analysis of 🚶🏽‍♀️🚶‍♂️ & QOL benefits of SGLT2i across sex, DM, EF in > 22000 pts JAMA Network Open!

+13 m can mean diff btwn being confined to one’s 🏡 or being able to 🚶🏽‍♀️ across the st.

🙌🏽 context 📖 before #ACC24 - where effects of empagliflozin in setting…

.Brigham and Women’s Research Clinical Trials Outcomes Center American College of Cardiology #ACC24

Incredibly proud of this diverse group of talented investigators, featuring
🔥 Young Investigator Award Session
🔥 Highlighted Original Research
🔥 >10 Simultaneous Publications

Excited to see everyone in ATL!

The Lancet podcast is out! Easily digestible bite-size answers to commonly asked questions about our paper HFpEF - everything the clinician needs to know. Check out myself and co-author Frans Rutten on thelancet.com/lancet/audio

Combination Rx is now standard of care across #CKM

#CKD (+T2D) Circulation
RASi+SGLT2i+nsMRA+GLP1RA
ahajournals.org/doi/10.1161/CI…

#HFrEF JACC Journals #JACCHF
ARNI+BB+MRA+SGLT2i
jacc.org/doi/10.1016/j.…

#HFmrEF / #HFpEF JACC Journals #JACCHF
ARNI+MRA+SGLT2i(+/-BB)
jacc.org/doi/10.1016/j.…